FIELD: medicine, oncology, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition used in treatment of solid tumors, for example, large intestine tumor, stomach tumor, breast tumor, ovary tumor, prostate tumor and kidney tumor, and these tumors are sensitive to effect of sodium meta-arsenite. Proposed composition comprises meta-arsenite (AsO2 -) salt taken in the pharmaceutically effective dose and pharmaceutically acceptable accessory agent. Also, invention relates to using this composition in treatment of solid tumors in a patient, and to a method for treatment of solid tumor showing sensitivity to effect of sodium meta-arsenite. Invention provides enhancing effectiveness in treatment of solid tumors.
EFFECT: valuable medicinal property of pharmaceutical composition, enhanced effectiveness of treatment.
13 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR TREATING CANCER | 2009 |
|
RU2508116C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING CANCER AND ITS METASTASES | 2006 |
|
RU2401662C2 |
| COMBINED COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING BENZOPHENONE-THIAZOLE DERIVATIVES AS VDA AND TOPOISOMERASE INHIBITOR | 2017 |
|
RU2724341C1 |
| ANTI-CANCER THERAPY, DIRECTED AGAINST CANCER STEM CELLS AND FORMS OF CANCER, RESISTANT TO TREATMENT BY MEDICATIONS | 2010 |
|
RU2568834C2 |
| ISOXAZOLE DERIVATIVE FOR TREATING CANCER | 2008 |
|
RU2491938C2 |
| USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION | 2013 |
|
RU2665362C2 |
| USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2630574C2 |
| MEDICATIONS FOR CANCER TREATMENT | 2008 |
|
RU2481830C2 |
| COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
| METHOD FOR MAKING AND PRESCRIBING SPHAELACTONE DERIVATE AND ITS COMPOSITES | 2011 |
|
RU2537319C2 |
